AE Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,731
| Closed | -$237K | – | 2162 |
|
|
2025
Q1 | $237K | Buy |
1,731
+141
| +9% | +$19.3K | ﹤0.01% | 1205 |
|
|
2024
Q4 | $243K | Buy |
+1,590
| New | +$243K | ﹤0.01% | 1188 |
|
|
2024
Q3 | – | Sell |
-1,118
| Closed | -$259K | – | 1241 |
|
|
2024
Q2 | $259K | Buy |
+1,118
| New | +$259K | ﹤0.01% | 1077 |
|
|
2024
Q1 | – | Sell |
-2,014
| Closed | -$493K | – | 1222 |
|
|
2023
Q4 | $493K | Buy |
2,014
+348
| +21% | +$85.2K | ﹤0.01% | 1443 |
|
|
2023
Q3 | $428K | Buy |
1,666
+398
| +31% | +$102K | ﹤0.01% | 1459 |
|
|
2023
Q2 | $361K | Sell |
1,268
-79
| -6% | -$22.5K | ﹤0.01% | 1530 |
|
|
2023
Q1 | $374K | Buy |
1,347
+493
| +58% | +$137K | ﹤0.01% | 1460 |
|
|
2022
Q4 | $236K | Sell |
854
-20,042
| -96% | -$5.55M | ﹤0.01% | 1602 |
|
|
2022
Q3 | $5.58M | Buy |
+20,896
| New | +$5.58M | 0.04% | 410 |
|
|
2021
Q4 | – | Sell |
-1,085
| Closed | -$307K | – | 1695 |
|
|
2021
Q3 | $307K | Buy |
1,085
+277
| +34% | +$78.4K | ﹤0.01% | 1353 |
|
|
2021
Q2 | $280K | Sell |
808
-12,707
| -94% | -$4.4M | ﹤0.01% | 1362 |
|
|
2021
Q1 | $3.78M | Buy |
13,515
+5,953
| +79% | +$1.67M | 0.04% | 378 |
|
|
2020
Q4 | $1.85M | Sell |
7,562
-6,352
| -46% | -$1.56M | 0.02% | 515 |
|
|
2020
Q3 | $3.95M | Buy |
13,914
+7,477
| +116% | +$2.12M | 0.06% | 273 |
|
|
2020
Q2 | $1.72M | Buy |
6,437
+4,524
| +236% | +$1.21M | 0.03% | 448 |
|
|
2020
Q1 | $605K | Sell |
1,913
-41
| -2% | -$13K | 0.01% | 620 |
|
|
2019
Q4 | $580K | Buy |
1,954
+380
| +24% | +$113K | 0.01% | 690 |
|
|
2019
Q3 | $366K | Sell |
1,574
-2,111
| -57% | -$491K | 0.01% | 711 |
|
|
2019
Q2 | $862K | Buy |
3,685
+2,683
| +268% | +$628K | 0.03% | 447 |
|
|
2019
Q1 | $237K | Buy |
+1,002
| New | +$237K | 0.02% | 548 |
|